Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze

RATIONALE: Cannabidiol (CBD), the major non-psychoactive constituent of cannabis, has therapeutic potential for the treatment of anxiety. Most preclinical studies investigate only acute effects of CBD and only in males, yet the drug is most likely to be used over a sustained period in clinical pract...

Descripción completa

Detalles Bibliográficos
Autores principales: Fabris, Débora, Carvalho, Milene C, Brandão, Marcus L, Prado, Wiliam A, Zuardi, Antônio W, Crippa, José A, de Oliveira, Amanda R, Lovick, Thelma A, Genaro, Karina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716492/
https://www.ncbi.nlm.nih.gov/pubmed/36239039
http://dx.doi.org/10.1177/02698811221125440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716492/
https://www.ncbi.nlm.nih.gov/pubmed/36239039
http://dx.doi.org/10.1177/02698811221125440

Ejemplares similares